188 related articles for article (PubMed ID: 17719319)
1. Predictors of in-stent restenosis and patient outcome after percutaneous coronary intervention in patients with diabetes mellitus.
Sukhija R; Aronow WS; Sureddi R; Aleti S; Molavi B; Sachdeva R; Mehta JL
Am J Cardiol; 2007 Sep; 100(5):777-80. PubMed ID: 17719319
[TBL] [Abstract][Full Text] [Related]
2. Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (the PRESTO trial).
Assali AR; Moustapha A; Sdringola S; Denktas AE; Willerson JT; Holmes DR; Smalling RW
Am J Cardiol; 2006 Sep; 98(6):729-33. PubMed ID: 16950172
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.
Qasim A; Cosgrave J; Latib A; Colombo A
Am J Cardiol; 2007 Dec; 100(11):1619-24. PubMed ID: 18036358
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting: a comparison of bare metal stent and drug eluting stent.
Ma HY; Zhou YJ; Dick RJ; Shi DM; Liu YY; Cheng WJ; Guo YH; Wang JL; Ge HL
Chin Med J (Engl); 2008 May; 121(10):887-91. PubMed ID: 18706201
[TBL] [Abstract][Full Text] [Related]
6. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508
[TBL] [Abstract][Full Text] [Related]
7. Preprocedural white blood cell count and major adverse cardiac events late after percutaneous coronary intervention in saphenous vein grafts.
Upadhya B; Applegate RJ; Sane DC; Deliargyris EN; Kutcher MA; Gandhi SK; Baki TT; Call JT; Little WC
Am J Cardiol; 2005 Aug; 96(4):515-8. PubMed ID: 16098303
[TBL] [Abstract][Full Text] [Related]
8. Different impacts of C-reactive protein and lipid profile on coronary lesions following a percutaneous coronary intervention.
Xu HY; Qiao SB; Zhang JF; Dong QT; Li JJ
Coron Artery Dis; 2012 May; 23(3):181-7. PubMed ID: 22336660
[TBL] [Abstract][Full Text] [Related]
9. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW;
J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986
[TBL] [Abstract][Full Text] [Related]
10. Comparison of effectiveness and safety of sirolimus-eluting stents versus bare-metal stents in patients with diabetes mellitus (from the Italian Multicenter Randomized DESSERT Study).
Maresta A; Varani E; Balducelli M; Varbella F; Lettieri C; Uguccioni L; Sangiorgio P; Zoccai GB;
Am J Cardiol; 2008 Jun; 101(11):1560-6. PubMed ID: 18489933
[TBL] [Abstract][Full Text] [Related]
11. Impact of low high-density lipoproteins on in-hospital events and one-year clinical outcomes in patients with non-ST-elevation myocardial infarction acute coronary syndrome treated with drug-eluting stent implantation.
Wolfram RM; Brewer HB; Xue Z; Satler LF; Pichard AD; Kent KM; Waksman R
Am J Cardiol; 2006 Sep; 98(6):711-7. PubMed ID: 16950168
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome does not increase angiographic restenosis rates after drug-eluting stent implantation.
Canibus P; Faloia E; Piva T; Muçai A; Serenelli M; Perna GP; Boscaro M; Piva R
Metabolism; 2008 May; 57(5):593-7. PubMed ID: 18442619
[TBL] [Abstract][Full Text] [Related]
13. Clinical presentation of patients with in-stent restenosis in the drug-eluting stent era.
Lee MS; Pessegueiro A; Zimmer R; Jurewitz D; Tobis J
J Invasive Cardiol; 2008 Aug; 20(8):401-3. PubMed ID: 18688064
[TBL] [Abstract][Full Text] [Related]
14. Endothelial vasomotor dysfunction in the brachial artery is associated with late in-stent coronary restenosis.
Kitta Y; Nakamura T; Kodama Y; Takano H; Umetani K; Fujioka D; Saito Y; Kawabata K; Obata JE; Ichigi Y; Mende A; Kugiyama K
J Am Coll Cardiol; 2005 Aug; 46(4):648-55. PubMed ID: 16098430
[TBL] [Abstract][Full Text] [Related]
15. Clinical in-stent restenosis with bare metal stents: is it truly a benign phenomenon?
Bainey KR; Norris CM; Graham MM; Ghali WA; Knudtson ML; Welsh RC;
Int J Cardiol; 2008 Aug; 128(3):378-82. PubMed ID: 17689711
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
[TBL] [Abstract][Full Text] [Related]
17. Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry).
Yan BP; Duffy SJ; Clark DJ; Lefkovits J; Warren R; Gurvitch R; Lew R; Sebastian M; Brennan A; Andrianopoulos N; Reid CM; Ajani AE;
Am J Cardiol; 2008 Jun; 101(12):1716-22. PubMed ID: 18549846
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of preintervention C-reactive protein on clinical outcome after directional coronary atherectomy followed by stent implantation.
Niccoli G; Ferrante G; Mongiardo R; Perfetti M; Belloni F; Burzotta F; Porto I; Leone AM; Rebuzzi AG; Crea F
Cardiovasc Revasc Med; 2007; 8(3):156-60. PubMed ID: 17765643
[TBL] [Abstract][Full Text] [Related]
19. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians.
Rodés-Cabau J; Deblois J; Bertrand OF; Mohammadi S; Courtis J; Larose E; Dagenais F; Déry JP; Mathieu P; Rousseau M; Barbeau G; Baillot R; Gleeton O; Perron J; Nguyen CM; Roy L; Doyle D; De Larochellière R; Bogaty P; Voisine P
Circulation; 2008 Dec; 118(23):2374-81. PubMed ID: 19029471
[TBL] [Abstract][Full Text] [Related]
20. Everolimus- and zotarolimus-eluting stents for bare metal stent in-stent restenosis treatment: a prospective study.
Toutouzas K; Patsa C; Tsiamis E; Tsioufis C; Spanos A; Stefanadi E; Tentolouris C; Stefanadis C
J Interv Cardiol; 2008 Oct; 21(5):388-94. PubMed ID: 18705639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
